SHBG and prostate carcinoma: SHBG was inversely associated with overall and early‐onset prostate cancer in blood‐based analyses (0.91, 0.89‐0.93 and 0.83, 0.74‐0.95, respectively), but was not associated with aggressive disease risk (0.97, 0.91‐1.04) (Figure 1).